11/16/2026 | Press release | Distributed by Public on 11/16/2026 06:31
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The information contained in this quarter report on Form 10-Q is intended to update the information contained in our Form 10-K, dated April 13, 2026, for the year ended December 31, 2025 and presumes that readers have access to, and will have read, the "Management's Discussion and Analysis of Financial Condition and Results of Operations" and other information contained in such Form 10-K. The following discussion and analysis also should be read together with our unaudited condensed consolidated financial statements and the notes to the unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q.
The following discussion contains certain statements that may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements appear in a number of places in this Report, including, without limitation, "Management's Discussion and Analysis of Financial Condition and Results of Operations." These statements are not guarantees of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements speak only as of the date of this quarterly report. You should not put undue reliance on any forward-looking statements. We assume no responsibility to update the forward-looking statements contained in this transition report on Form 10-Q. The following should also be read in conjunction with the unaudited condensed Consolidated Financial Statements and notes thereto that appear elsewhere in this report.
Company Overview
Agape ATP Corporation, a Nevada corporation ("the Company") was incorporated under the laws of the State of Nevada on June 1, 2016.
Agape ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation ("AATP LB"), a company incorporated in Labuan, Malaysia, and Agape Superior Living Sdn. Bhd. ("ASL"), a company incorporated in Malaysia on August 8, 2003.
AATP LB is an investment holding company with 100% equity interest in Agape ATP International Holding Limited ("AATP HK"), a company incorporated in Hong Kong.
On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd., a network marketing entity incorporated in Malaysia.
On September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn. Bhd. ("WATP"), a wholly owned subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle. On July 4, 2024, the entity changed its name to Cedar ATPC Sdn. Bhd. ("CEDAR").
On November 25, 2024, CEDAR increased its number of ordinary shares to 1,000,000 shares at RM 0.01 per share.
On November 11, 2021, AATP LB formed an entity, DSY Wellness International Sdn. Bhd. ("DSY Wellness") with an independent third party which AATP LB owns 60% of the equity interest, to pursue the business of providing complementary health therapies. On June 11, 2026, AATP LB disposed of all of its 60% equity interest in DSY Wellness to the same independent third party pursuant to the board resolution, resulting in the Company losing control of DSY Wellness.
The Company and its subsidiaries are principally engaged in the skin care and health Industry. The principal activity of the Company is to supply high-quality skin care and health products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various health programs.
The Company positioned itself for sustainable growth by diversifying its operations into the domain of renewable energy. This initiative is founded upon our commitment to environmental responsibility, long-term value creation, and proactive adaptation to global energy trends. On January 3, 2024, the Company formed an equity method investment entity, OIE ATPC Holdings (M) Sdn. Bhd. with Oriental Industries Enterprise (M) Sdn. Bhd. ("OIE"), which the Company and OIE each own 50% of the equity interest. On March 14, 2024, the Company acquired 50% of OIE ATPC Holdings (M) Sdn. Bhd. equity interest from OIE, subsequently the entity becomes a wholly owned subsidiary of the Company. On June 7, 2024, the entity changed its name to ATPC Green Energy Sdn. Bhd ("AGE").
On September 19, 2024, AGE increased its number of ordinary shares to 1,000,000 shares at RM 0.01 per share.
On January 8, 2024, AGE formed a wholly own entity, OIE ATPC Exim (M) Sdn. Bhd ("ATPC Exim"). However, the Company had decided not to proceed with the continued development of ATPC Exim. There is no impact to the Group's operation.
On December 25, 2024, the Company incorporated ATPC Technology Private Limited ("ATPC Tech") in China, a wholly owned subsidiary in AATP HK to collaborate with local IT expertise to develop comprehensive digital wellness platform that integrates e-commerce, online consultations, chronic disease management, and robust supply chain services catering to ASEAN market.
Results of Operation
For the three months ended September 30, 2026 and 2025
Revenue
We generated revenue of $4,798 from the Company's network marketing business, which represented 100% of the revenue, no revenue from skin care and healthcare products and the operation in green energy for the three months ended September 30, 2026 as compared to $109,024, which comprised revenue from the Company's network marketing business of $17,186 (approximately 15.8% of total revenue); $90,564 from skin care and healthcare products (approximately 83.1% of total revenue) and $1,274 from the operation in green energy (approximately 1.2% of total revenue) for the three months ended September 30, 2025.
Revenue from the Company's network marketing business decreased by $12,388, or approximately 72.1%. Revenue from skin care and healthcare products decreased by 100% from $90,564 to $0 and revenue from operation in green energy decreased by 100% from $1,274 to $0. Total revenue decreased by $104,226, or approximately 95.6%.
The decrease in revenue from the Company's network marketing business was primarily due to limited product range available for sale compared to the prior year period. The decrease in revenue from the Company's wellness and wellbeing lifestyle business was due to the company's decision to put the wellness and wellbeing lifestyle operations on hold. The decrease in revenue from the Company's operation in green energy was due to the Company did not secure any new projects during the current period.
Cost of Revenue
Cost of revenue typically comprise of freight-in, cost of goods purchased, packing materials and services acquired. Cost of revenue for the three months ended September 30, 2026 amounted to $379 as compared to $16,726 for the three months ended September 30, 2025, a decrease of $16,347, or approximately 97.7%. The decrease was due to the declined in cost of revenue in the Company's operations in wellness and wellbeing lifestyle and operation in green energy.
Gross Profit
Gross profit for the three months ended September 30, 2026 amounted to $4,419, represented a gross margin of approximately 92.1% as compared to $92,298 for the three months ended September 30, 2025, equivalent to a gross margin of approximately 84.7%. The significant increase in gross margin was due to the Company's network marketing business contribute higher gross profit margin as compared to Company's operations in wellness and wellbeing lifestyle and operation in green energy.
Operating Expenses
Our operating expenses consist of selling expenses, commission expenses and general and administrative expenses (as defined below). Total operating expenses were $411,626 for the three months ended September 30, 2026, decreased by $261,826 or approximately 38.9% from $673,452 for the three months ended September 30, 2025.
Selling expenses
Selling expenses for the three months ended September 30, 2026 amounted to $28,895 as compared to $58,891 for the three months ended September 30, 2025, a decrease of $29,996, or approximately 50.9%. The Company's selling expenses typically comprise of salaries and benefits expenses, credit card processing fees, advertisement and promotional expenses.
Commission expenses
Commission expenses were $889 and $27,386 for the three months ended September 30, 2026 and 2025, respectively, a decrease of $26,947, or approximately 96.8%. The Company pays commission in Company's network marketing business and the operation in wellness and wellbeing lifestyle. The decrease in commission expenses was due to the decline in both revenue of network marketing business and the operation in wellness and wellbeing lifestyle.
General and administrative expenses ("G&A Expenses")
G&A expenses for the three months ended September 30, 2026 amounted to $381,842, as compared to $587,175 for the three months ended September 30, 2025, a decrease of $205,333, or approximately 35.0%. The Company's G&A expenses typically comprise of salaries and benefits expenses, rental expenses, professional expenses, depreciation expenses and other expenses. The decrease in G&A expenses was mainly due to no activity in the operation in wellness and wellbeing lifestyle.
Other Income (Expenses), Net
For the three months ended September 30, 2026, the Company recorded an amount of $323,729 as other income, net, as compared to $7,141 as other income, net, for the three months ended September 30, 2025, represented a significant increase of $316,588 in other income, net, or approximately 4,433.4%.
The other income, net of $323,729 generated during the three months ended September 30, 2026 comprised of other income, net of $1,000, unrealized holding loss on marketable securities of $8,156, loss on disposal of assets of $14, foreign currency exchange gain of $330,899. The significant foreign currency exchange gain was primarily due to the appreciation of the CNY against the US$ during the period, which resulted in an increase in the US$ equivalent value of the deposits denominated in CNY. The other income, net of $7,141 generated during the three months ended September 30, 2025 comprised of other income, net of $2,768, unrealized holding loss on marketable securities of $3,487 and foreign currency exchange gain of $7,860.
Income Tax Expense
The Company recorded provision for income taxes of $206 and $0 for the three months ended September 30, 2026 and 2025, respectively. The provision for income taxes were in respect of the Company's operations in Malaysia.
Net Loss
Net loss decreased by $511,686 from a net loss of $595,370 for the three months ended September 30, 2025 to a net loss of $83,684 for the three months ended September 30, 2026, mainly due to reasons as discussed above.
For the nine months ended September 30, 2026 and 2025
Revenue
We generated revenue of $40,079 which comprised revenue from the Company's network marketing business of $25,240 (approximately 63.0% of total revenue); $14,839 from skin care and healthcare products (approximately 37.0% of total revenue) and no revenue from the operation in green energy for the nine months ended September 30, 2026 as compared to $352,844, which comprised revenue from the Company's network marketing business of $59,882 (approximately 17.0% of total revenue); $154,689 from skin care and healthcare products (approximately 43.8% of total revenue) and $138,273 from the operation in green energy (approximately 39.2% of total revenue) for the nine months ended September 30, 2025.
Revenue from the Company's network marketing business decreased by $34,642, or approximately 57.9%. Revenue from skin care and healthcare products decreased by $139,850 or approximately 90.4% and revenue from operation in green energy decreased by 100% from $138,273 to $0. Total revenue decreased by $312,765, or approximately 88.6%.
The decrease in revenue from the Company's network marketing business was primarily due to limited product range available for sale compared to the prior year period. The decrease in revenue from the Company's wellness and wellbeing lifestyle business was due to the company's decision to put the wellness and wellbeing lifestyle operations on hold. The decrease in revenue from the Company's operation in green energy was due to the Company did not secure any new projects during the current period.
Cost of Revenue
Cost of revenue typically comprise of freight-in, cost of goods purchased, packing materials and services acquired. Cost of revenue for the nine months ended September 30, 2026 amounted to $7,597 as compared to $173,396 for the nine months ended September 30, 2025, a decrease of $165,799, or approximately 95.6%.
The decrease was due to the declined in cost of revenue in the Company's operations in wellness and wellbeing lifestyle and operation in green energy.
Gross Profit
Gross profit for the nine months ended September 30, 2026, amounted to $32,482, represented a gross margin of approximately 81.0% as compared to $179,448 for the nine months ended September 30, 2025, equivalent to a gross margin of approximately 50.9%. The increase in gross margin was due to the Company's network marketing business contribute higher gross profit margin as compared to Company's operations in wellness and wellbeing lifestyle and operation in green energy.
Operating Expenses
Our operating expenses consist of selling expenses, commission expenses, general and administrative expenses. Total operating expenses were $1,634,798 for the nine months ended September 30, 2026, decreased by $432,817 or approximately 20.9% from $2,067,615 for the nine months ended September 30, 2025.
Selling expenses
Selling expenses for the nine months ended September 30, 2026 amounted to $93,982 as compared to $179,290 for the nine months ended September 30, 2025, a decrease of $85,308, or approximately 47.6%, mainly due to the decrease in advertisement cost and marketing event related expenses. The Company's selling expenses typically comprise of salaries and benefits expenses, credit card processing fees, advertisement and promotional expenses.
Commission expenses
Commission expenses were $8,734 and $51,350 for the nine months ended September 30, 2026 and 2025, respectively, a decrease of $42,616, or approximately 83.0%. The Company pays commission in the Company's network marketing business and the operation in wellness and wellbeing lifestyle. The decrease in commission expenses was due to the decline in both revenue of network marketing business and the operation in wellness and wellbeing lifestyle.
General and administrative expenses
G&A expenses for the nine months ended September 30, 2026 amounted to $1,532,082, as compared to $1,836,975 for the nine months ended September 30, 2025, a decrease of $304,893, or approximately 16.6%. The decrease in G&A expenses was due to fewer activities in the operation in wellness and wellbeing lifestyle. The Company's G&A expenses typically comprise of salaries and benefits expenses, rental expenses, professional expenses, depreciation expenses and other expenses.
Other Income (Expenses), Net
For the nine months ended September 30, 2026, the Company recorded an amount of $1,294,741 as other income, net, as compared to $28,335 other income, net, for the nine months ended September 30, 2025, represented a significant increase of $1,266,406 in other income, net, or approximately 4,469.4%.
The other income, net of $1,294,741 generated during the nine months ended September 30, 2026 comprised of other income, net of $5,869, unrealized holding loss on marketable securities of $11,311, gain on disposal of assets of $1,799 and foreign currency exchange gain of $1,298,384. The significant foreign currency exchange gain was primarily due to the appreciation of the CNY against the US$ during the period, which resulted in an increase in the US$ equivalent value of the deposits denominated in CNY. The other income, net of $28,335 generated during the nine months ended September 30, 2025 comprised of other income, net of $14,764, interest income of $3,416, unrealized holding gain on marketable securities of $3,165 and foreign currency exchange gain of $6,990.
Income Tax Expense
The Company recorded provision for income taxes of $206 and $0 for the nine months ended September 30, 2026 and 2025, respectively. The provision for income taxes were in respect of the Company's operations in Malaysia.
Net Loss
Net loss decreased by $1,656,382 from net loss of $1,931,535 for the nine months ended September 30, 2025 to net loss of $275,153 for the nine months ended September 30, 2026, mainly due to reasons as discussed above.
Liquidity and Capital Resources
As of September 30, 2026, the Company had working capital of $21,822,336 consisting of cash and cash in bank of $47,538 as compared to working capital of $22,236,994 consisted of cash and cash in bank of $89,651 as of December 31, 2025. The Company had a net loss of $275,153 for the nine months ended September 30, 2026 and accumulated deficits of $12,056,136 as compared to net loss of $2,307,607 for the year ended December 31, 2025 and accumulated deficits of $11,797,836 as of December 31, 2025.
The Company's liquidity remains subject to substantial doubt regarding its ability to continue as a going concern. Although the Company had current assets of $25,131,513 as of September 30, 2026, substantially all of these assets consisted of $24,868,438 deposit paid to Bi Cheng Investment Management Limited to identify and manage investment opportunities, for which no investment had been identified as of the reporting date. Management intends to improve liquidity by increasing revenue, controlling operating costs and expenses, obtaining additional financing, and pursuing new investment opportunities. However, there can be no assurance that these plans will be successfully implemented or that they will generate sufficient cash flows to support the Company's operations.
The following summarizes the key components of our cash flows for the nine months ended September 30, 2026 and 2025:
|
For the nine months ended September 30, |
||||||||
| 2026 | 2025 | |||||||
| Net cash used in operating activities from continuing operations | $ | (434,045 | ) | $ | (2,193,537 | ) | ||
| Net cash used in operating activities from discontinued operations | (40,637 | ) | (11,537 | ) | ||||
| Net cash provided by (used in) investing activities from continuing operations | 144 | (23,000,000 | ) | |||||
| Net cash used in investing activities from discontinued operations | (5,208 | ) | (667 | ) | ||||
| Net cash provided by financing activities from continuing operations | 391,565 | 23,303,990 | ||||||
| Net cash used in financing activities from discontinued operations | (5,421 | ) | (6,981 | ) | ||||
| Effect of exchange rate on cash and cash equivalents | 1,068 | 2,203 | ||||||
| Decrease in cash and cash equivalents | $ | (92,534 | ) | $ | (1,906,529 | ) | ||
Operating activities
Net cash used in operating activities for the nine months ended September 30, 2026 was $474,682, comprised of net loss of $307,781 from continuing operations and net loss of $42,132 from discontinued operations, gain on disposal of discontinued operations of $74,760, unrealized exchange gain of $1,304,678, the increase in other receivables from related parties of $253, the decrease in account payable (including related parties) of $30, the decrease in customer deposits of $15,194, the payment of operating lease liabilities of $89,786, the decrease of income tax payable of $1,145 and the net cash used in discontinued operations of $40,637. The net cash used in operating activities was mainly offset by non-cash depreciation and amortization expense of $1,514, amortization of finance assets of $20,122, amortization of operating right-of-use assets of $89,340, unrealized holding loss on marketable securities of $11,311, inventory write off of $2,071, allowance for credit loss $5,597, the decrease in accounts receivables of $4,716, the decrease in inventories of $2,780, the decrease in prepaid taxes of $7,039, the decrease in prepayments and deposits of $57,928, the decrease in other receivables of $30, the increase in other payables (including related parties) and accrued liabilities of $40,632 and the increase in amount due to directors of $1,041,742.
Net cash used in operating activities for the nine months ended September 30, 2025 was $2,205,074, comprised of net loss of $1,859,832 from continuing operations and net loss of $71,703 from discontinued operations, unrealized holding gain on marketable securities of $3,165, the increase in prepayments and deposits of $455,627, the decrease in account payable (including related parties) $43,251, the decrease in customer deposits of $6,213, the payment of operating lease liabilities of $117,172, the decrease in other payables (including related parties) and accrued liabilities of $116,846 and the net cash used in discontinued operations of $11,537. The net cash used in operating activities was mainly offset by non-cash depreciation and amortization expense of $16,116, amortization of finance assets of $18,713, amortization of operating right-of-use assets of $116,549, inventory write off of $6,961, allowance for credit loss of $38,779, the decrease in accounts receivables of $6,836, the decrease in amount due from related parties of $141, the decrease in inventories of $1,781, the decrease in other receivables of $2,517 and the increase in amount due to directors of $200,176.
Investing activities
Net cash used in investing activities for the nine months ended September 30, 2026 was $5,064, which comprised of $144 from the proceeds of disposal of subsidiary and $5,208 from discontinued operations, which was the effect of disposal of subsidiary.
Net cash used in investing activities for the nine months ended September 30, 2025 was $23,000,667, which comprised of $23,000,000 for advances for investment and $667 from discontinued operations.
Financing activities
Net cash provided by financing activities for the nine months ended September 30, 2026 was $386,144, consisted of payment of finance lease liability of $10,924, the advance from director of $496,147, payment of deferred offering costs of $93,658 and net cash used of $5,421 from discontinued operations.
Net cash provided by financing activities for the nine months ended September 30, 2025 was $23,297,009, consisted of the proceeds from issuance of common stock for $23,000,000, payment of finance lease liability of $9,729, advance from director of $313,719 and net cash used of $6,981 from discontinued operations.
Credit Facilities
We do not have any credit facilities or other access to bank credit.
Off-Balance Sheet Arrangements
As of September 30, 2026, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.
Critical Accounting Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company's unaudited condensed consolidated financial statements include allowance for inventories obsolescence, impairment of long-lived assets, allowance for deferred tax assets, allowance for credit loss, allowance for estimation of coupon redemption and the assumptions used in the valuation of the derivative financial instruments. Following are the methods and assumptions used in determining our estimates.
Estimated allowance for inventories obsolescence
Management reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net realizable value. For the nine months ended September 30, 2026 and 2025, there were no inventory write-down, however, there were $2,071 and $6,961 inventory write-off respectively.
Impairment of long-lived assets
Operating right-of-use assets and property, plant and equipment are stated at costs less accumulated depreciation and impairment, if any. In determining whether an asset is impaired, the Company has to exercise judgment and make estimation, particularly in assessing: (1) whether an event has occurred or any indicators that may affect the asset value; (2) whether the carrying value of an asset is not recoverable that is its carrying amount exceeds the amount of expected undiscounted future cash flows result from the use of the asset. Once it is established that impairment has occurred, the amount of impairment expense is determined as the difference between the carrying value of the asset and its estimated fair value based on a discounted cash flows approach.
As of September 30, 2026 and December 31, 2025, the carrying amounts of operating right-of-use assets amounted to $5,162 and $102,101, respectively, and property, plant and equipment amounted to $3,615 and $5,140, respectively. No impairment losses on operating right-of-use assets and property, plant and equipment were recognized as of September 30, 2026 and December 31, 2025.
Allowance for deferred tax assets
The Company conducts its business activities primarily in Malaysia. The Company also has entities incorporated in China and Hong Kong, which currently have no business activities. Notwithstanding this, all these entities are subject to tax in their respective jurisdictions. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. Where the final tax outcome of these matters is different from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.
Deferred tax assets relating to certain temporary differences and tax losses are recognized as management considers it is more likely than not that future taxable profit will be available against which the temporary differences or tax losses can be utilized. Where the expectation is different from the original estimate, such differences will impact the recognition of deferred tax assets and taxation in the periods in which such estimate is changed.
Allowance for credit loss
The Company estimates and records an allowance for credit loss related to its accounts receivable. Credit losses are determined by Current Estimate of Expected Credit Losses model in accordance with Topic 326 - Financial Instruments - Credit Losses. For accounts receivable, the Company considers the age of the accounts receivable balances, credit quality of the Company's customers based on ongoing credit evaluations, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect the Company's ability to collect from customers.
Allowance for estimation of coupon redemption
The Company offers various coupon programs to customers, which result in the potential redemption of coupons against future purchases. The estimation of coupon redemption requires assumptions. This estimate is based on historical redemption patterns, customer behavior trends, and the terms and conditions of the coupon programs. Management considers factors such as the type of coupon, the period of validity that could influence redemption rates. The Company makes estimates about the likelihood and timing of coupon redemptions, which may vary based on changing customer behavior and economic conditions. If the actual redemption rate differs from the estimated rate, it could impact the redemption liability and related expenses in future periods. The allowance for coupon redemption is regularly reviewed and adjusted as more information becomes available to ensure that it reflects the expected redemption accurately.
Assumptions used in the valuation of the derivative financial instruments
The Company issued Representative's Warrants to purchase up to 115.50 shares of common stock at $4,400.00 per share, dated October 13, 2023, to Network 1 Financial Securities, Inc. The warrants shall be exercisable at any time, and from time to time, in whole or in part, commencing from October 13, 2023 (i.e. the date of issuance) and expiring on October 10, 2028. The Company used Black-Scholes-Merton Model to estimate the fair value of the Warrants and recognized as equity. No subsequent measurement has been performed as the Warrants are classified as equity.
Critical Accounting Policies
Revenue recognition
The Company adopted Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core principle underlying the revenue recognition of this ASU allows the Company to recognize revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company's revenue streams are recognized at a point in time for the Company's sale of skin care and health products.
The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.
The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.
Sales of Skin Care and Health products
- Performance obligations satisfied at a point in time
The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the skin care and health products are transferred to its customer at the Company's office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.
Under the Company's network marketing business, the Company issues product coupons to members and distributors when these customers made purchases above certain thresholds set by the Company. Depending on the type of product coupons issued, the coupons carry varying values and can be used by the customers for reduction in the transaction price of product purchases within the coupon validity period. The value of the product coupons issued is recorded as a reduction of the Company's revenue account upon issuance; the corresponding amount credited to the customer deposits account. Amounts in customer deposits will be reversed when the coupons are used. The Company's coupons have a validity period of between six and twelve months. If the Company's customers did not utilize the coupons after the validity period, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues.
Sales of products and services for the operations in green energy
- Performance obligations satisfied over time
The Company provides products, technical knowledge and solutions for sustainability and energy savings. The Company delivered the products to the customers and enhances the products that the customer controls. The products that the Company created has no alternative use to the Company. The Company has an enforceable right to receive payment for performance completed to date, the Company recognized revenue based on the percentage of cost incurred.
Fair value of financial instruments
The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.
The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:
| ● | Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. | |
| ● | Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. | |
| ● | Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. |
Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.
Accounting Standards Adopted in 2026
In November 2024, the FASB issued ASU 2024-04 "Debt - Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments". This ASU clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The clarification is effective for annual reporting periods beginning after December 15, 2025, and interim periods within those fiscal years. Early adoption is permitted. The adoption of ASU 2024-04 has no material impact on the Company consolidated financial statements.
In July 2025, the FASB issued ASU 2025-05 "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets". This ASU provides a practical expedient that allows companies to assume that current conditions as of the balance sheet date do not change for the remaining life of the asset. This ASU is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within annual reporting periods. Early adoption is permitted. The adoption of ASU2025-05 has no material impact on the Company's consolidated financial statements.
Except for the above-mentioned pronouncements, there are no new recent issued accounting standards that will have a material impact on the unaudited condensed consolidated financial position, statements of operations and cash flows.
Recent accounting pronouncements
The Company has reviewed all recently issued, but not yet effective, considers the applicability and impact of all accounting standards updates ("ASUs"). Management periodically reviews new accounting standards that are issued.
The FASB issued ASU 2024-03 and ASU 2025-01 "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, and Clarifying the Effective Date" in November 2024 and January 2025, respectively. This new guidance requires disclosures of additional information of the nature of expenses included in the income statement as well as disclosures about specific expense categories in the notes to the financial statements. The requirements of the new guidance are effective for annual periods beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, which early adoption permitted. This new guidance can be applied either retrospectively to any or all prior periods presented in the consolidated financial statements or prospectively to financial statements issued for reporting period after the effective date of this new guidance. The Company is currently evaluating the effect of adopting this guidance.
In September 2025, the FASB issued ASU 2025-06 "Intangibles - Goodwill and Other-Internal-Use Software (Subtopic 350-40). This ASU updates the accounting for internal-use software by replacing former stage-based rules with a principles-based framework. Entities will now capitalize costs associated with internal-use software only when management has authorized and committed funding and it is probable that the project will be completed and the software will be used to perform the intended function. It also supersedes website development cost guidance, moving it to ASC 350-40. This ASU is effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the effect of adopting of this ASU.
In December 2025, the FASB issued ASU 2025-11 "Interim Reporting (Topic 270): Narrow-Scope Improvements". This ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. This ASU is effective for interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the effect of adopting of this ASU.
In December 2025, the FASB issued ASU 2025-12 "Codification Improvements". This ASU represents changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. This ASU is effective for annual reporting periods beginning after December 15, 2026, and interim periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the effect of adopting of this ASU.
In May 2026, the FASB issued ASU 2026-02 "Environmental Credits and Environmental Credit Obligations (Topic 818)". This ASU creates ASC Topic 818 to establish a comprehensive framework for accounting and reporting related to environmental credits (such as emissions allowances, renewable energy certificates, and carbon offsets) and environmental credit obligations (ECO). Under ASC Topic 818, environmental credits are recognized as assets at cost based on their intended use, while costs for non-qualifying or voluntary credits are expensed as incurred. ECO liabilities are recognized when probable and measured on a gross basis using the carrying amount of credits held for the funded portion and fair value (or expected settlement cost) for the unfunded portion. This ASU is effective for annual reporting periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the effect of adopting of this ASU.
Except for the above-mentioned pronouncements, there are no other new recent issued accounting standards that will have a material impact on the consolidated financial position, statements of operations and cash flows.